| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444855 | European Journal of Cancer | 2013 | 8 Pages |
Abstract
Aflibercept 4Â mg/kg plus irinotecan-LV5FU2 every 2Â weeks had acceptable toxicity and pharmacokinetics, and showed promising antitumour activity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
David Khayat, Sabine Tejpar, Jean-Philippe Spano, Chris Verslype, Joël Bloch, Vincent Vandecaveye, Sylvie Assadourian, Karen Soussan-Lazard, Sylvaine Cartot-Coton, Eric Van Cutsem,